Why Your Hair Gets Thinner Over Time: The Role of DHT Explained

Sudha Mishra | Nov 03, 2026, 12:50 IST
Share
Hairloss
Hairloss

Androgenetic hair loss does not happen overnight. DHT binds to receptors in genetically susceptible follicles and sets off a slow process of miniaturisation that plays out over years, sometimes decades. Understanding what is actually happening inside the follicle, and why it matters which stage you are at, changes how you think about every intervention on offer.

Highlights
  • Dihydrotestosterone, or DHT, results from the conversion of testosterone by the enzyme 5-alpha reductase and is linked to androgenetic hair loss due to certain hair follicles being more sensitive to it.
  • The hair growth cycle involves active growth, a transitional phase, and resting, with a key process called miniaturisation reducing hair thickness and length as DHT affects genetically susceptible follicles over time.
  • Effective treatments for androgenetic hair loss, such as finasteride and dutasteride, require ongoing use and work best when follicles are still active, emphasizing the importance of early identification and intervention.
Most people notice the result long after the process has been running. A wider parting, a temple that has quietly receded, a ponytail that feels thinner than it used to. By the time the change is visible, the follicles driving it have already been shrinking for years.

What DHT Is and Where It Comes From

Dihydrotestosterone, or DHT, is a hormone produced when an enzyme called 5-alpha reductase converts testosterone. This conversion happens in several tissues, including the skin and scalp. DHT is not abnormal. It plays a role in male development and is present in both men and women. The problem in androgenetic hair loss is not an excess of DHT in the blood, most people with pattern hair loss have DHT levels within a normal range. The problem is that certain follicles carry androgen receptors that are unusually sensitive to it.

How DHT Shrinks a Follicle Over Time

A hair follicle is not a fixed tube. It cycles through active growth (anagen), a short transitional phase (catagen), and rest (telogen), after which it sheds the hair and begins again. In a healthy follicle, the anagen phase lasts two to six years. Each cycle produces a hair of roughly the same diameter and length as the last.

When DHT binds to androgen receptors in a genetically susceptible follicle, it triggers changes in the dermal papilla, the cluster of cells at the base of the follicle that controls hair growth. Over successive cycles, the anagen phase shortens. A follicle that once spent four years in active growth may spend eighteen months, then six months, then weeks. Each shortened cycle produces a thinner, shorter, more lightly pigmented hair. This is miniaturisation. The follicle does not disappear immediately; it produces progressively finer vellus-like hairs until, in advanced cases, it becomes dormant. At that point, the window for reversal has largely closed.

The process is slow enough that many people do not connect what they see in the mirror with what started years earlier. It is also patchy in a predictable way: follicles on the crown and temples carry more androgen receptors than follicles at the sides and back, which is why the back of the scalp is the donor site in transplant surgery, those follicles retain their resistance to DHT regardless of where they are placed.

Why This Matters for How You Think About Treatment

Treatments for androgenetic hair loss work at different points in this process, and the stage you are at determines what is realistically achievable.

Finasteride and dutasteride, both prescription-only oral medications, inhibit 5-alpha reductase and reduce the amount of DHT available to bind to follicle receptors. They work best when follicles are still active, even if miniaturised. They cannot revive a follicle that has been dormant long enough to lose its dermal papilla structure. Topical minoxidil, also available in prescription-strength formulations, works differently, it prolongs the anagen phase and increases blood flow to the follicle, but it does not address DHT directly. Stopping either medication typically means the process resumes. These are not one-time fixes; they require ongoing use to maintain effect, and results vary considerably between individuals.

PRP, or platelet-rich plasma, involves drawing a small amount of the patient's blood, concentrating the growth factors in it, and injecting that concentrate into the scalp. The proposed mechanism is that growth factors stimulate the dermal papilla and may extend the anagen phase in weakened follicles. Evidence is mixed, and the quality of PRP varies significantly by protocol and clinic. It is generally considered an adjunct rather than a primary treatment.

Hair transplant surgery, whether FUT strip or FUE follicle extraction, moves DHT-resistant follicles from the back of the scalp to areas of loss. It does not stop the underlying process. Follicles that were already miniaturising in the recipient area before the transplant continue to do so. Planning a transplant without addressing the ongoing loss often means further thinning around the transplanted hair over the following years.

Who Should Know This Is Not the Only Cause of Hair Loss

Androgenetic hair loss has a specific presentation: gradual, patterned, and tied to family history on either side. It is not the same as telogen effluvium, which is diffuse shedding triggered by a stressor, illness, significant weight loss, a nutritional deficiency, postpartum hormonal shifts, or thyroid dysfunction. Telogen effluvium is usually temporary once the cause is addressed. Treating it as androgenetic hair loss, or vice versa, delays the right intervention.

Traction alopecia, caused by chronic tension from tight hairstyles, and scalp inflammation from conditions like seborrheic dermatitis or lichen planopilaris are also distinct causes with different treatment paths. A dermatologist can usually distinguish these through clinical examination and, where needed, a scalp biopsy. Self-diagnosing pattern hair loss and starting DHT-blocking medication without ruling out other causes is not a safe shortcut, some causes of hair loss worsen with the wrong treatment.

The earlier androgenetic hair loss is identified and addressed, the more follicles are still in a state where intervention can slow or partially reverse miniaturisation. That is not a reason to panic at the first shed. It is a reason to get a proper assessment rather than waiting until the change is impossible to miss.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!